Overview

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Status:
Completed

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer survival.

Phase:

Phase 3

Details

Lead Sponsor:

International Breast Cancer Research Foundation

Collaborator:

Breast Cancer Research Foundation

Treatments:

Hormones
Tamoxifen